Institute for Cancer Genetics, Columbia University Medical Center, New York, NY 10032, USA.
Proteomics Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA.
Mol Cell. 2020 Aug 6;79(3):376-389.e8. doi: 10.1016/j.molcel.2020.06.021. Epub 2020 Jul 7.
Activation of dual-specificity tyrosine-phosphorylation-regulated kinases 1A and 1B (DYRK1A and DYRK1B) requires prolyl hydroxylation by PHD1 prolyl hydroxylase. Prolyl hydroxylation of DYRK1 initiates a cascade of events leading to the release of molecular constraints on von Hippel-Lindau (VHL) ubiquitin ligase tumor suppressor function. However, the proline residue of DYRK1 targeted by hydroxylation and the role of prolyl hydroxylation in tyrosine autophosphorylation of DYRK1 are unknown. We found that a highly conserved proline in the CMGC insert of the DYRK1 kinase domain is hydroxylated by PHD1, and this event precedes tyrosine autophosphorylation. Mutation of the hydroxylation acceptor proline precludes tyrosine autophosphorylation and folding of DYRK1, resulting in a kinase unable to preserve VHL function and lacking glioma suppression activity. The consensus proline sequence is shared by most CMGC kinases, and prolyl hydroxylation is essential for catalytic activation. Thus, formation of prolyl-hydroxylated intermediates is a novel mechanism of kinase maturation and likely a general mechanism of regulation of CMGC kinases in eukaryotes.
双特异性酪氨酸磷酸化调节激酶 1A 和 1B(DYRK1A 和 DYRK1B)的激活需要 PHD1 脯氨酰羟化酶对脯氨酸进行羟化。DYRK1 的脯氨酸羟化作用引发了一系列事件,导致了 von Hippel-Lindau(VHL)泛素连接酶肿瘤抑制功能的分子约束的释放。然而,被羟化作用靶向的 DYRK1 的脯氨酸残基以及脯氨酸羟化作用在 DYRK1 的酪氨酸自身磷酸化中的作用尚不清楚。我们发现,DYRK1 激酶结构域的 CMGC 插入中的一个高度保守的脯氨酸被 PHD1 羟化,并且该事件先于酪氨酸自身磷酸化。羟化作用接受脯氨酸的突变排除了酪氨酸自身磷酸化和 DYRK1 的折叠,导致激酶无法保留 VHL 功能并且缺乏神经胶质瘤抑制活性。该共识脯氨酸序列被大多数 CMGC 激酶共享,并且脯氨酸羟化对于催化激活是必需的。因此,形成脯氨酰羟化中间产物是一种激酶成熟的新机制,并且可能是真核生物中 CMGC 激酶调节的一般机制。